Indian indices are down 3.5% so far in October, influenced by geopolitical tensions and foreign outflows. Yes Securities ...

According to data from the BSE index, the stock has achieved multibagger gains over the last two years, climbing 122.04%.

Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest innovations enabling the ...

Mylan and Novo Nordisk have reached a confidential settlement over the generic version of Ozempic, with Natco Pharma holding ...

The week has started with reports that activist investor Starboard Value has amassed a $1 billion stake in pharma group ...

Nuvama Insitutional Equities initiated coverage on Jubilant Pharmova Ltd. with a 'buy' rating and estimated the stock price ...

Finolex Industries Ltd, Astrazeneca Pharma India Ltd, Macrotech Developers Ltd and JK Lakshmi Cement Ltd are among the other gainers in the BSE's 'A' group today, 07 October 2024.

Off the scrapheap of discarded drugs and on its way to becoming the most highly anticipated approval of 2024, Bristol Myers ...

Mylan Pharmaceuticals Inc and Novo Nordisk, the original patent holder for Ozempic, have reached a settlement in the US ...

Gilead Merger AstraZeneca, the UK’s largest drugmaker valued at $140bn, has reportedly contacted Gilead Sciences, an American ...

The company described the move as a “mass layoff of its sales representatives and related employees across the country,” ...